Your browser doesn't support javascript.
loading
Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A phase III, randomized, double-blind, placebo-controlled, parallel study.
Ji, Linong; Lu, Yibin; Li, Qifu; Fu, Liujun; Luo, Yong; Lei, Tao; Li, Ling; Ye, Shandong; Shi, Bimin; Li, Xiyan; Meinicke, Thomas.
Afiliación
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, People's Republic of China.
  • Lu Y; Department of Endocrinology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China.
  • Li Q; Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
  • Fu L; Department of Endocrinology, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, People's Republic of China.
  • Luo Y; Department of Endocrinology, Chongqing University Three Gerges Hospital, Chongqing, People's Republic of China.
  • Lei T; Department of Endocrinology, Putuo District Central Hospital of Shanghai, Shanghai, People's Republic of China.
  • Li L; Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, People's Republic of China.
  • Ye S; Department of Endocrinology, The First Affiliated Hospital of USTC, Hefei, People's Republic of China.
  • Shi B; Department of Endocrinology, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Li X; Biostatistics and Data Sciences, Boehringer Ingelheim (China) Investment Co. Ltd, Shanghai, People's Republic of China.
  • Meinicke T; Therapeutic Area Cardiovascular/Metabolism/Respiratory, Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Diabetes Obes Metab ; 25(7): 1839-1848, 2023 07.
Article en En | MEDLINE | ID: mdl-36864540
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article